PFG Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
ECSS
CIM
ATO
PFG Advisors's GILD Position: Q2 2026 in Review
PFG Advisors reduced its Gilead Sciences (GILD) stake by 27% in Q2 2026, selling an estimated $138K and leaving 2,755 shares worth $348K. The position accounts for 0.02% of the portfolio, ranked #628.
PFG Advisors first reported a position in GILD in Q4 2018 and has held it in 22 quarters since. The position peaked at $695K in Q3 2025. 874 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- PFG Advisors held 2,755 shares of Gilead Sciences worth $348K as of Q2 2026.
- PFG Advisors sold 1,044 Gilead Sciences shares in Q2 2026, an estimated $138K.
- Gilead Sciences made up 0.02% of PFG Advisors's portfolio in Q2 2026, its #628 holding.
- PFG Advisors first reported a position in Gilead Sciences in Q4 2018 and has held it in 22 quarters since.
- PFG Advisors's Gilead Sciences position peaked at $695K in Q3 2025.
- 874 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on PFG Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.